Sanofi

Sanofi

Sanofi

Overview
Date Founded

1973

Headquarters

54, rue La Boétie,Paris, Ile-de-France 75008

Type of Company

Public

Employees (Worldwide)

104K

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
Hospitals & Patient Services
Medical Support Services

Company Description

Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health

Contact Data
Trying to get in touch with decision makers at Sanofi? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Director & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Executive Vice President, Legal Affairs & General Counsel

Chief Regulatory Officer

Chief Digital Officer

Executive Vice President & General Manager, Diabetes & Cardiovascular

Executive Vice President & General Manager, Sanofi Pasteur

President, Merial North America

Executive Vice President & Head-Business Transformation

Head of IR North America & Asia

Board of Directors

Founder at Weinberg Capital Partners SAS

Director & Chief Executive Officer at Sanofi

President at Truffle Capital

Partner at Morgan, Lewis & Bockius LLP

Vice Chairman & Chief Executive Officer at Dassault Systèmes SA

Executive Vice President & Chief Financial Officer at L'Oréal SA

Deputy Chief Executive Officer, Finance & Legal Affairs at Schneider Electric SE

Investigator at Howard Hughes Medical Institute, Inc.

Director at Air Liquide USA LLC

Paths to Sanofi
Potential Connections via
Relationship Science
You
Sanofi
Owners & Shareholders
Details Hidden

Dodge & Cox's investment decisions are made by a team of seasoned investment professionals based on key fundamental factors that they believe determine investment value over the long term. The firm's investment analysts operate from a single location to foster communication and collaboration and each investment idea is subject to committee review for both its merits as a specific investment and its role in the overall portfolio. Their approach stresses an evaluation of risk relative to opportunity and we seek investments that we believe are undervalued by the market. Fundamental bottom-up research, a rigorous valuation discipline and a long-term investment horizon are central to Dodge & Cox's investment philosophy.

Details Hidden

Amundi-IM invests through funds in all asset classes and main currencies. The firm believes that overall analysis of a company, including economic, social and environmental aspects, allows for better assessment of the risks and opportunities that may affect its long-term valuation.

Details Hidden

BNPPAM manages a range of active investment strategies - both fundamental and quantitative, in addition to strategies managed to replicate specific indices and benchmarks - across a wide universe of assets extending from equities, fixed income, multi-asset and LDI solutions to alternatives. Their investment teams share a number of common beliefs: there are opportunities to maximize long-term returns in inefficient markets; a combination of systematic evaluation and qualitative insight is the best way to identify opportunities; a disciplined, consistent investment process is vital for investment success over the long term; and risk management needs to be fully embedded in the investment process.

Recent Transactions
Details Hidden

Recipharm AB purchases Sanofi /CMO Business from Sanofi

Details Hidden

Sanofi purchases Ablynx NV

Details Hidden

Coopération Pharmaceutique Française SAS, Damier NV purchase Sanofi /12 Pharmaceutical Brands from Sanofi

Transaction Advisors
Legal Advisor

Advised onSanofi purchases Sanofi Genzyme

Legal Advisor

Advised onSanofi purchases TargeGen, Inc.

Legal Advisor

Advised onSanofi purchases Sanofi Genzyme

Legal Advisor

Advised onSanofi purchases Sanofi Genzyme

Legal Advisor

Advised onSanofi purchases Bioverativ, Inc.

Legal Advisor

Advised onSanofi purchases TargeGen, Inc.

Advisors & Consultants
Legal Advisor

Partner at Jones Day

Legal Advisor

Partner at Jones Day

Legal Advisor

Second Vice President-Trustees Board at Greenwich Library

Clients

Taisho Pharmaceutical Holdings Co. Ltd. engages in the management and administration of its group companies that manufactures and sells over-the-counter (OTC) drugs, foods, and other goods, etc. It operates through the following segments: Self-Medication and Prescription Pharmaceutical. The Self-Medication segment conducts research and development (R&D), manufacturing and sale of over-the-counter drugs, quasi-drugs, food, and general medical and hygiene supplies. The Prescription Pharmaceutical segment handles R&D, manufacturing, and sale of ethical drugs. It also provides the manufacture and sale of prescription pharmaceuticals; and businesses incidental or related thereto. The company was founded on October 3, 2011 and is headquartered in Tokyo, Japan.

Chongqing Zhifei Biological Products Co., Ltd. engages in the wholesale of biological products and vaccines. Its main products are meningococcal group A&C conjugate vaccine, meningococcal polysaccharide vaccine, mycobacterium vaccae, Haemophilus Influenzae type b conjugate vaccine, and freeze-dried live attenuated hepatitis A vaccine. Its other activities are biotechnology research, development, and consulting; import and export, and storage services. The company was founded on July 20, 1995 and is headquartered in Chongqing, China.

Universal Robina Corp. is engaged in the manufacture and distribution of consumer food products. It operates through the following segments: Branded Consumer Foods, Agro-Industrial Products, Commodity Food Products, and Corporate Business. The Branded Consumer Foods segment manufactures and distributes salty snacks, chocolates, candies, biscuits, bakery products, beverages, instant noodles, pasta and tomato-based products. The Agro-Industrial Products segment produces and distributes an animal health products, animal feeds, glucose and soya bean products; and operates hog and poultry farm. The Commodity Food Products segment refines sugar and flour as well as manufactures pasta. Its products include savory snacks, biscuits, cakes, candies, chocolates, ready-to-drink tea and coffee; juices, bottled water, energy drinks, pure and blended coffee; creamer, instant coffee and chocolate mixes; pouch and cup noodles; canned beans, sauces and tomato paste. The Corporate Business segment engages in bonds and securities investment and fund sourcing activities. The company was founded by John L. Gokongwei Jr. on September 28, 1954 and is headquartered in Quezon City, Philippines.

Key Stats and Financials As of 2018
Market Capitalization
$97.8B
Total Enterprise Value
$113B
Earnings Per Share
$3.46
Revenue
$34.5B
Net Profit
$4.32B
EBITDA
$8.54B
EBITDAMargin
24.79%
Total Debt
$24.6B
Total Equity
$59B
Enterprise Value Sales
3.27x
Enterprise Value EBITDAOperating
13.21x
TEVNet Income
26.13x
Debt TEV
0.22x
Three Year Compounded Annual Growth Rate Of Revenue
-0.08%
Five Year Compounded Annual Growth Rate Of Revenue
0.9%
Investments
Details Hidden

NJOY LLC manufactures and distributes electronic cigarettes. Its products include kings, express starter kits, cartridge refills and onejoy disposable ecigs. The company offers a variety of rechargeable and non-rechargeable electronic cigarette products made for adult smokers. It provides nicotine and rich tobacco and menthol flavor without smoke or odor. NJOY was founded by Mark H. Weiss and Craig Weiss in 2006 and is headquartered in Scottsdale, AZ.

Details Hidden

Part of Kiri Industries Ltd., Dystar Holdings GmbH is a German company that functions as investment holding company.

Details Hidden

Thermalin Diabetes LLC develops insulin treatments for patients with diabetes. It offers ultra-rapid acting insulins that are taken before meals to dampen glucose spikes; and long acting insulins for promoting non-mealtime basal level in diabetes patients. The company was founded by Michael Weiss and Richard Berenson in 2009 and is headquartered in Cleveland, OH.

Investors
Details Hidden

Founder at Icahn Associates Holding LLC

Details Hidden

Chief Executive Officer at Prognomix, Inc.

Suppliers
Publicis Groupe SA Hospitals & Patient Services | Paris, IF

Publicis Groupe SA engages in the advertising industry. Its services include customer relationship management, direct marketing, sales promotion, events management, public relations, corporate, multicultural and financial communications. The company was founded by Marcel Bleustein-Blanchet in 1926 and is headquartered in Paris, France.

Sodexo SA Other Business & Consulting Services | Issy-les-Moulineaux, IF

Sodexo SA engages in the provision of on-site services, benefits and rewards services, and personal and home care services. It offers integrated solutions which cover a variety of working and living environments and are available in client segments which include corporate, health care, education, defense, remote sites, justice services, seniors, and sports and leisure. Sodexo was founded by Pierre Bellon in 1966 and is headquartered in Issy-les-Moulineaux, France.

Neurones SA Internet Software & Services | Nanterre, IF

Neurones SA engages in providing management consulting and information technology services. Its services include infrastructure, application and management consultations. The company operates business through its segments: Infrastructure Services, Application Services and Consulting. The Infrastructure Services segment engages in the systems and networks, service desk, workstation outsourcing, server and application outsourcing in cloud, computing mode, IT security, IT operations, IT service management and IT governance. The Application Services segment engages in the web and decision support BI, IT consulting for finance, SAP, content management and business process management, IT training and change management. The Consulting segment engages in the management and organization consulting. The company was founded on December 5, 1984 and is headquartered in Nanterre, France.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sanofi. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sanofi's profile does not indicate a business or promotional relationship of any kind between RelSci and Sanofi.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/sanofi-92731
  • https://relationshipscience.com/organization/sanofi-92731